247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Syngene International Limited IPO (Syngene International IPO) Details

Syngene International Limited is an Pharmaceutical based company, located in Bangalore, Syngene International Limited IPO size was 550.00 Cr. and was issued at 250.00 per share. The share of Syngene International Limited were listed at 310.40 per share and are currently trading at 820.35 per share.

Type :
Sub Sector : Development And Manufacturing At Its Ultra Modern World Class Research And Development Facility
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
871.60 Cr.

PAT :
175.00 Cr.

Pricing Report

Issue Price :
250.00

Listing Price :
310.40

Current Market Price :
820.35

Issue Price vs CMP :
570.35 (228.14%)

listing Price vs CMP :
509.95 (164.29%)

Performance Report (CAGR* wise)

CAGR : 13.4
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Syngene International

Company Information
Syngene International Limited is one of the leading India-based contract research organizations (CRO), offering a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across various industrial sectors, including pharmaceuticals, biotechnology, agrochemicals, consumer health, animal health, cosmetics, and nutrition companies. Its service offerings in discovery and development span multiple domains, including small molecules, large molecules, antibody-drug conjugates (ADC), and oligonucleotides.

The company's integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluations, formulation development, and stability studies), and pilot manufacturing (scale-up, pre-clinical, and clinical supplies) under one roof, providing a distinctive economic advantage. The company's services also support the development of biosimilar and generic molecules. In
Show More
Object of Issue
  • Achieve the benefits of listing the Equity Shares on the Stock Exchanges
  • Enhance visibility and brand image among existing and potential clients and
  • Provide liquidity to the existing shareholders

Syngene International MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Aug, 2015
IPO Size :
550.00 Cr.
IPO Subscription :
32.05 X     
PE Multiple :
27.00
Merchant Banker :
Axis Bank Limited
IPO Registrar:
Kfin Technologies Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Bangalore

Aadhar Housing Finance Limited

  low income housing segment

  Bangalore


Archidply Industries Limited

  plywood manufacturing

  Bangalore


Barbeque Nation Hospitality Limited

  operates 153+ Barbeque Nation restaurants in India and Gulf countries

  Bangalore


Peer Companies Of This Sector

FAQs

Syngene International operates in Pharmaceutical and Development And Manufacturing At Its Ultra Modern World Class Research And Development Facility. The Issue is listed on MainBoard in Aug, 2015. Syngene International IPO size was 550.00 Cr. with Issue price of 250.00 .

Merchant Banker(s) of Syngene International IPO: Axis Bank Limited , Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited

Syngene International IPO subscription was 32.05 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Syngene International IPO listed at a listing price of 310.40 against the offer price of 250.00.

The current market price of Syngene International is 820.35.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency